Frank Thomas
Präsident bei ORCHARD THERAPEUTICS PLC
Vermögen: 94 100 $ am 31.05.2024
Profil
Mr. Frank E.
Thomas, CPA, is a President & Chief Operating Officer at Orchard Therapeutics (Europe) Ltd., a President, Chief Operating & Financial Officer at Orchard Therapeutics Plc, an Independent Director at Spero Therapeutics, Inc. and an Independent Director at Larimar Therapeutics, Inc. He is on the Board of Directors at Spero Therapeutics, Inc., Larimar Therapeutics, Inc. and Orchard Therapeutics North America.
Mr. Thomas was previously employed as an Independent Director by Zafgen, Inc., a President & Chief Operating Officer by AMAG Pharmaceuticals, Inc., a Chief Operating Officer & Senior Vice President by Molecular Biometrics LLC, a President, Chief Executive Officer & Director by Critical Therapeutics, Inc., a Chief Financial Officer & VP-Investor Relations by HDL Therapeutics, Inc., a Controller & Finance Director by Mechanical Dynamics, Inc., and a Principal by Arthur Andersen LLP.
He also served on the board at Massachusetts Biotechnology Council.
He received his undergraduate degree from the University of Michigan.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
SPERO THERAPEUTICS, INC.
0,10% | 29.05.2024 | 55 000 ( 0,10% ) | 78 100 $ | 31.05.2024 |
29.05.2024 | 2 000 ( 0,00% ) | 16 000 $ | 31.05.2024 |
Aktive Positionen von Frank Thomas
Unternehmen | Position | Beginn |
---|---|---|
SPERO THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 06.09.2017 |
ORCHARD THERAPEUTICS PLC | Präsident | 18.03.2020 |
LARIMAR THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.01.2014 |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | Präsident | 17.03.2020 |
Orchard Therapeutics North America
Orchard Therapeutics North America BiotechnologyHealth Technology Part of Orchard Therapeutics Plc, Orchard Therapeutics North America provides biotechnology research services. The company is based in Boston, MA. The CEO of the company is Bobby Gaspar. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Frank Thomas
Unternehmen | Position | Ende |
---|---|---|
AMAG PHARMACEUTICALS, INC. | Vorstandsvorsitzender | 14.05.2012 |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Direktor/Vorstandsmitglied | 01.01.2015 |
Molecular Biometrics, Inc.
Molecular Biometrics, Inc. Miscellaneous Commercial ServicesCommercial Services Molecular Biometrics, Inc. used to develop analytical methodologies for molecular diagnostic. It developed highly specific and sensitive analytical methodologies for molecular diagnostic and monitoring applications in medicine, and for drug discovery and development through pharmacodiagnostics. The company was founded in 2005 and was headquartered in Norwood, MA. | Finanzdirektor/CFO | 18.01.2010 |
Critical Therapeutics, Inc. | Vorstandsvorsitzender | 31.03.2008 |
░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Frank Thomas
University of Michigan | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
ESPERION THERAPEUTICS, INC. | Health Technology |
SPERO THERAPEUTICS, INC. | Health Technology |
LARIMAR THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 10 |
---|---|
Critical Therapeutics, Inc. | Health Technology |
Mechanical Dynamics, Inc.
Mechanical Dynamics, Inc. Information Technology ServicesTechnology Services Part of Hexagon AB, Mechanical Dynamics, Inc. develops, markets, and supports virtual prototyping solutions. The company is based in Ann Arbor, MI. The company was founded by Michael E. Korybalski. Mechanical Dynamics was acquired by MSC Software Corp., part of Hexagon AB from April 26, 2017 on May 14, 2002 for $117 million. | Technology Services |
Molecular Biometrics, Inc.
Molecular Biometrics, Inc. Miscellaneous Commercial ServicesCommercial Services Molecular Biometrics, Inc. used to develop analytical methodologies for molecular diagnostic. It developed highly specific and sensitive analytical methodologies for molecular diagnostic and monitoring applications in medicine, and for drug discovery and development through pharmacodiagnostics. The company was founded in 2005 and was headquartered in Norwood, MA. | Commercial Services |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Commercial Services |
Arthur Andersen LLP
Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL. | Commercial Services |
AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
Zafgen, Inc.
Zafgen, Inc. BiotechnologyHealth Technology Zafgen, Inc. is a biopharmaceutical company, which engages in the development of novel therapies for patients affected by complex metabolic diseases. It focuses on the study of MetAP2 inhibitors in both common and rare metabolic disorders. The firm also advancing programs for type 2 diabetes, Prader-Willi syndrome, and liver diseases. The company was founded on November 22, 2005 and is headquartered in Boston, MA. | Health Technology |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | Health Technology |
Orchard Therapeutics Plc
Orchard Therapeutics Plc Pharmaceuticals: MajorHealth Technology Orchard Therapeutics Plc is a biopharmaceutical company, which engages in discovering, acquiring, developing and commercializing gene therapies for patients with rare disorders. The company focuses on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. Its portfolio includes Strimvelis, a commercial-stage gamma retroviral-based product for the treatment of Adenosine deaminase deficiency (ADA-SCID). The company was founded by Nicolas Koebel and Andrea Spezzi in August 2018 and is headquartered in London, the United Kingdom. | Health Technology |
Orchard Therapeutics North America
Orchard Therapeutics North America BiotechnologyHealth Technology Part of Orchard Therapeutics Plc, Orchard Therapeutics North America provides biotechnology research services. The company is based in Boston, MA. The CEO of the company is Bobby Gaspar. | Health Technology |